(Q46407913)

English

Efficacy and safety levels of preserved and preservative-free tafluprost are equivalent in patients with glaucoma or ocular hypertension: results from a pharmacodynamics analysis

scientific article published in January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752510

Efficacy and safety levels of preserved and preservative-free tafluprost are equivalent in patients with glaucoma or ocular hypertension: results from a pharmacodynamics analysis (English)

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752510

0 references

ocular hypertension

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

Juhani Airaksinen

2

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752510

author name string

Thomas Hamacher

1

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752510

Ville Saarela

3

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752510

M Johanna Liinamaa

4

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752510

Ulrich Richter

5

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752510

Auli Ropo

6

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752510

publication date

1 January 2008

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752510

Acta ophthalmologica. Supplement

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752510

242

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752510

14-19

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752510

Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2008.01381.X

21 January 2018

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2008.01381.X

21 January 2018

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2008.01381.X

21 January 2018

Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2008.01381.X

21 January 2018

Pharmacokinetics, efficacy and safety profiles of preserved and preservative-free tafluprost in healthy volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2008.01381.X

21 January 2018

Identifiers

10.1111/J.1755-3768.2008.01381.X

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752510

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18752510

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46407913&oldid=2143953442"